Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Therapeutic targets in focal and segmental glomerulosclerosis.

Lavin PJ, Gbadegesin R, Damodaran TV, Winn MP.

Curr Opin Nephrol Hypertens. 2008 Jul;17(4):386-92. doi: 10.1097/MNH.0b013e32830464f4. Review.

2.

Podocyte injury and targeting therapy: an update.

Durvasula RV, Shankland SJ.

Curr Opin Nephrol Hypertens. 2006 Jan;15(1):1-7. Review.

PMID:
16340659
3.

[Structure and function of the glomerular filtration barrier].

Musiał K, Zwolińska D.

Pol Merkur Lekarski. 2005 Mar;18(105):317-20. Review. Polish.

PMID:
15997642
4.

Focal segmental glomerulosclerosis: recent advances.

Pollak MR.

Curr Opin Nephrol Hypertens. 2008 Mar;17(2):138-42. doi: 10.1097/MNH.0b013e3282f5dbe4. Review.

PMID:
18277145
5.

The podocyte's response to injury: role in proteinuria and glomerulosclerosis.

Shankland SJ.

Kidney Int. 2006 Jun;69(12):2131-47. Epub 2006 May 10. Review.

6.

Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.

Szabó T, Ambrus L, Zákány N, Balla G, Bíró T.

Acta Physiol Hung. 2015 Sep;102(3):241-51. doi: 10.1556/036.102.2015.3.2. Review.

PMID:
26551740
7.

The role of podocytes in glomerular pathobiology.

Asanuma K, Mundel P.

Clin Exp Nephrol. 2003 Dec;7(4):255-9. Review.

PMID:
14712353
8.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Ziyadeh FN, Wolf G.

Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.

PMID:
18220694
9.

The pathogenesis of focal segmental glomerulosclerosis.

Jefferson JA, Shankland SJ.

Adv Chronic Kidney Dis. 2014 Sep;21(5):408-16. doi: 10.1053/j.ackd.2014.05.009. Review.

10.

Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.

Kawachi H, Suzuki K, Miyauchi N, Hashimoto T, Otaki Y, Shimizu F.

Clin Exp Nephrol. 2009 Aug;13(4):275-80. doi: 10.1007/s10157-009-0162-x. Epub 2009 Mar 7. Review.

PMID:
19266252
11.

Pathogenesis of nonimmune glomerulopathies.

Kwoh C, Shannon MB, Miner JH, Shaw A.

Annu Rev Pathol. 2006;1:349-74. Review.

PMID:
18039119
12.

Genetic kidney diseases disclose the pathogenesis of proteinuria.

Jalanko H, Patrakka J, Tryggvason K, Holmberg C.

Ann Med. 2001 Nov;33(8):526-33. Review.

PMID:
11730159
13.

Targeting podocyte-associated diseases.

Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R.

Adv Drug Deliv Rev. 2010 Nov 30;62(14):1325-36. doi: 10.1016/j.addr.2010.08.012. Epub 2010 Sep 7. Review.

PMID:
20828590
14.

The spectrum of focal segmental glomerulosclerosis: new insights.

D'Agati VD.

Curr Opin Nephrol Hypertens. 2008 May;17(3):271-81. doi: 10.1097/MNH.0b013e3282f94a96. Review.

PMID:
18408478
15.

Podocyte biology in segmental sclerosis and progressive glomerular injury.

Barisoni L.

Adv Chronic Kidney Dis. 2012 Mar;19(2):76-83. doi: 10.1053/j.ackd.2012.02.018. Review.

PMID:
22449344
16.

Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.

Löwik MM, Groenen PJ, Levtchenko EN, Monnens LA, van den Heuvel LP.

Eur J Pediatr. 2009 Nov;168(11):1291-304. doi: 10.1007/s00431-009-1017-x. Epub 2009 Jun 27. Review.

17.

Targeting signaling pathways in glomerular diseases.

Henique C, Tharaux PL.

Curr Opin Nephrol Hypertens. 2012 Jul;21(4):417-27. doi: 10.1097/MNH.0b013e328354a598. Review.

PMID:
22660552
18.

Focal and segmental glomerulosclerosis: multiple pathways are involved.

Meyrier A.

Semin Nephrol. 2011 Jul;31(4):326-32. doi: 10.1016/j.semnephrol.2011.06.003. Review.

PMID:
21839365
19.

Mechanisms of disease: focal segmental glomerulosclerosis.

Meyrier A.

Nat Clin Pract Nephrol. 2005 Nov;1(1):44-54. Review.

PMID:
16932363
20.
Items per page

Supplemental Content

Write to the Help Desk